KANE MATTHEW R. 4

4 · PRECISION BIOSCIENCES INC · Filed May 11, 2021

Form 4

Period: 2021-05-07

DirectorPresident and CEO10% Owner

Transactions

Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-05-10−21,514→ 21,514 total
Exercise: $0.04Exp: 2021-05-17→ Common Stock (21,514 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-05-07−21,514→ 43,028 total
Exercise: $0.04Exp: 2021-05-17→ Common Stock (21,514 underlying)
Exercise/Conversion
Common Stock
2021-05-10$0.04/sh+21,514$861→ 2,011,504 total
Exercise/Conversion
Common Stock
2021-05-07$0.04/sh+21,514$861→ 1,999,732 total
Sale
Common Stock
2021-05-07$8.57/sh−9,742$83,489→ 1,989,990 total
Sale
Common Stock
2021-05-10$8.25/sh−9,746$80,405→ 2,001,758 total

Holdings

Footnotes (4)

[F1]All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.25 to $8.31. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]Shares are held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
[F4]The option is fully vested and exercisable.

Documents

1 file